STRUCTURAL HEART
SAPIEN 3 TAVR (26mm) via Percutaneous Femoral Access – January 2017
Views2402

84 year old female presented with chest pain and dyspnea on exertion (NYHA III). Her past history was significant for hypertension, hyperlipidemia, and DVT. TTE revealed severe valvular aortic stenosis; peak gradient = 68 mmHg, mean gradient = 41 mmHg, Doppler valve area = 0.7cm2, Aortic peak velocity = 4.1m/sec and LVEF of 51 %. Coronary angiogram showed mild (30-50%) mid LAD disease only. CT angiogram revealed minimum diameters of 8mm for bilateral common iliac arteries and aortic annulus of 21.6 X 26.7mm (average 24.4 mm) with an annular circumference of 75mm. Coronary ostial height was 10mm for left main and 15mm for RCA. The STS mortality risk for Surgical AVR is 3.4 % and the Logistic Euroscore mortality risk is 10.1%. Patient was determined to be intermediate risk for SAVR. Now planned for high risk TAVR with Sapien S3 (26mm) via percutaneous femoral access under conscious sedation and pre-empt LM protection.

1:01:13

comments

Leave Your Comments

suggestion
Suggestions
Valve-in-Valve TAVR with 26mm SAPIEN-3 – March 2019
Views247

79 year old man presents with worsening exertional dyspnea (NYHA Class III) for the last 3 months. Patient has required […]


50:31
Valve-in-Valve TAVR with 29mm Evolut-R CoreValve – January 2019
Views467

79 year old man presents with progressive exertional dyspnea (NYHA Class III) for the last 2 months.


1:07:06
TAVR 29mm Sapien-3 – November 2018
Tags:
Views670

96 year old male presents with progressive exertional dyspnea (NYHA Class III) for the last 4 months.


49:42
TAVR in a Patient with Prior Mitral Valve Replacement – September 2018
Tags: |
Views650

87 year old female presents with progressive exertional dyspnea (NYHA Class III) for the last 3 months.